U.S.' Chiron applies to EMEA for bird flu vaccine approval

02/27/2006 | Yahoo!

European authorities said Chiron Corp. has applied for preliminary approval of its H5N1 vaccine for treating a bird flu pandemic. GlaxoSmithKline was the first to apply under the European Medicines Agency's accelerated approvals procedure.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI